it is hoped the new approach will target cancer stem cells that evade conventional drugs and cause the tumour to re-grow .
it is hoped the new approach will target cancer stem cells that evade conventional drugs and cause tumours to re-grow .
they are testing the drug sulforadex in the most common type of breast cancer , affecting 70 per cent of patients .